Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: A report of two cases

Modern Rheumatology

Volumn 23, Issue 1, 2013, Pages 190-194

  Horai, Yoshiro ^a   Isomoto, Eriko ^b   Koga, Tomohiro ^a   Okada, Akitomo ^a   Kawashiri, Shin Ya ^a   Tamai, Mami ^a   Yamasaki, Satoshi ^a   Nakamura, Hideki ^a   Origuchi, Tomoki ^a   Hamaguchi, Yasuhito ^c   Fujimoto, Manabu ^c   Kuwana, Masataka ^d   Kawakami, Atsushi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b JAPANESE RED CROSS NAGASAKI GENBAKU HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyopathic dermatomyositis; Anti CADM 140 MDA5 antibody; Interstitial lung disease; Prognosis

Indexed keywords

ANTIBODY; C REACTIVE PROTEIN; CREATINE KINASE; MDA5 ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADULT; AMYOPATHIC DERMATOMYOSITIS; ARTHRALGIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DERMATOMYOSITIS; DYSPNEA; EARLY DIAGNOSIS; ERYTHEMA; FEMALE; FEVER; HUMAN; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LEUKOPENIA; LIVER DYSFUNCTION; MUSCLE WEAKNESS; OXYGEN SATURATION; PRIORITY JOURNAL; REMISSION; SPIROMETRY;

ADULT; AUTOANTIBODIES; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MUSCLE WEAKNESS; PEPTIDES; PROGNOSIS; PULSE THERAPY, DRUG; RADIOGRAPHY, THORACIC; RECOVERY OF FUNCTION; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84872491786     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0637-6     Document Type: Article

References (13)

1. Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22:639-43.
2. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571-6.
3. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;63:2193-200.
4. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626-36.
5. Lakhanpal H, Lie JT, Conn DL, Martin WJ 2nd. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis. 1987;46:23-9.
6. Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri S, Iwamoto N, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with dermatomyositis. Rheumatology (Oxford). 2012; in press.
7. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol. 1993;100:124S-7S.
8. Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol. 2009;28:979-84.
9. Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest. 2009;136:1341-7.
10. Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J. 2006;28:1005-12.
11. Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi. 2007;30:444-54.
12. Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49:1713-9.
13. Sato S. Autoantibodies specifically detected in patients with polymyositis/dermatomyositis. Nihon Rinsho Meneki Gakkai Kaishi. 2006;29:85-93.